Related Experiment Videos
[Clinico-immunologic correlations in disseminated sclerosis].
Zhurnal Nevropatologii I Psikhiatrii Imeni S.S. Korsakova (Moscow, Russia : 1952)
|January 1, 1984
Summary
Cellular and humoral immunity correlate with multiple sclerosis (MS) severity. Immune responses change during MS relapses and in progressive disease, suggesting personalized immunotherapy is needed.
Area of Science:
- Immunology
- Neurology
- Autoimmune Diseases
Context:
- Disseminated sclerosis (DS), also known as multiple sclerosis (MS), is a chronic autoimmune disease affecting the central nervous system.
- Understanding the immune system's role in MS pathogenesis is crucial for developing effective treatments.
Purpose:
- To investigate the correlation between cellular and humoral immunity and the clinical presentation of disseminated sclerosis.
- To identify specific immune markers associated with disease activity and progression in MS patients.
Summary:
- A study of 107 patients revealed that the intensity of cellular and humoral immunity correlates with the acuteness and severity of disseminated sclerosis.
- During disease exacerbations, patients showed decreased T lymphocyte activity (via lymphocyte blast transformation) and altered antibody levels (high cerebral, low complement-fixing).
- Reduced cellular reactivity was observed in patients with unfavorable, steadily progressing disease.
Impact:
- The findings highlight the necessity of a differential approach to immunotherapy for disseminated sclerosis.
- Immune deviations in both cellular and humoral immunity should be considered for personalized MS treatment strategies.